TNF-α-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients

被引:120
作者
Fernández-Mestre, MT
Gendzekhadze, K
Rivas-Vetencourt, P
Layrisse, Z
机构
[1] Inst Venezolano Invest Cient, Ctr Med Expt Miguel Layrisse, Lab Fisiopatol, Caracas 1020A, Venezuela
[2] Cent Univ Venezuela, Escuela Med JM Vargas, Unidad Invest Quirurg, Caracas, Venezuela
来源
TISSUE ANTIGENS | 2004年 / 64卷 / 04期
关键词
cytokines; dengue hemorrhagic fever; polymorphism;
D O I
10.1111/j.1399-0039.2004.00304.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Among the several hypothesis postulated to explain the pathogenesis of severe dengue disease, the model of immunopathogenesis is the most supported one with a likely important role played by the cascade of cytokines. This work describes single-nucleotide polymorphism of tumor necrosis factor (TNF)-alpha, interferon-gamma, interleukin (IL)-6, transforming growth factor-beta1, and IL-10 in patients with dengue virus infections and analyzes their relation with clinical manifestations of the disease. Because cytokine gene polymorphisms affect cytokine production, the significant increase of the TNF-308A allele we have observed among patients with dengue fever (DF) with hemorrhagic manifestations compared to patients with DF only indicates that the former patients are genetically predisposed to express higher levels of TNF-alpha. This finding supports studies reporting a possible association between elevated levels of circulating TNF, vascular permeability, and hemorrhage in patients with dengue hemorrhagic fever.
引用
收藏
页码:469 / 472
页数:4
相关论文
共 23 条
[1]   Characterisation of lymphocyte response and cytokine patterns in patients with Dengue fever [J].
Azeredo, EL ;
Zagne, SMO ;
Santiago, MA ;
Gouvea, AS ;
Santana, AA ;
Neves-Souza, PCF ;
Nogueira, RMR ;
Miagostovich, MP ;
Kubelka, CF .
IMMUNOBIOLOGY, 2001, 204 (04) :494-507
[2]  
Bunce M, 2000, HISTOCOMPATIBILITY TESTING, P149, DOI 10.1142/9781848160507_0010
[3]   POLYMORPHISM IN TUMOR-NECROSIS-FACTOR GENES ASSOCIATED WITH MUCOCUTANEOUS LEISHMANIASIS [J].
CABRERA, M ;
SHAW, MA ;
SHARPLES, C ;
WILLIAMS, H ;
CASTES, M ;
CONVIT, J ;
BLACKWELL, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1259-1264
[4]  
Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x
[5]  
Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt
[6]  
329::AID-JMV12&gt
[7]  
3.0.CO
[8]  
2-G
[9]  
HESSE R, 1999, J VIROL, V73, P4738
[10]   SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA), INTERLEUKIN-6 (IL-6), AND INTERLEUKIN-1-BETA (IL-1-BETA) IN DENGUE-INFECTED PATIENTS [J].
HOBER, D ;
POLI, L ;
ROBLIN, B ;
GESTAS, P ;
CHUNGUE, E ;
GRANIC, G ;
IMBERT, P ;
PECARERE, JL ;
VERGEZPASCAL, R ;
WATTRE, P ;
MANIEZMONTREUIL, M .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 48 (03) :324-331